Fundraising Fox
Biospectal
Founded 2017 · 5 employees on LinkedIn · 3 known investors
Find your way into Biospectal
Sign up to see every warm intro you have to Biospectal
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Biospectal team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.
Investors · 3
How we know: AEON Foundry's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$4.3M disclosed across 1 of 2 rounds · 2021
- Undisclosed amountSeed FundingJul 2021
SeedLink (lead)
Source ↗ - $4.3MraisedJul 2021 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Biospectal do?
- Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.
- Who are Biospectal's investors?
- Biospectal's investors include AEON Foundry, Privilège Ventures.
- How much funding has Biospectal raised?
- Biospectal has disclosed $4.3M raised across 1 of its 2 known rounds.